Previous Article | Next Article 
Journal of Virology, November 1999, p. 9266-9273, Vol. 73, No. 11
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Binding of Polyomavirus Small T Antigen to Protein Phosphatase 2A
Is Required for Elimination of p27 and Support of S-Phase Induction
in Concert with Large T Antigen
Stefan
Schüchner and
Erhard
Wintersberger*
Institute of Molecular Biology, University of
Vienna, A-1030 Vienna, Austria
Received 20 May 1999/Accepted 9 August 1999
 |
ABSTRACT |
Although polyomavirus large T antigen readily transactivates
S-phase-specific enzymes in serum-starved Swiss 3T3 mouse fibroblasts, it is incapable by itself to efficiently drive such cells into S phase.
We describe here that this inability correlates with a weak proficiency
of the viral protein to induce the synthesis of cyclin A and cyclin E
and to stimulate the respective cyclin/cdk activities. Polyomavirus
small T antigen, which together with the large T protein supports
S-phase induction, strongly contributes to the synthesis of cyclin A. In addition, small T antigen causes a dramatic induction of cyclin A-
and, together with large T antigen, of cyclin E-specific protein kinase
activity. This latter function of polyomavirus small T antigen
correlates with its competence to provoke the elimination of the kinase
inhibitor p27Kip1. An interaction of the small T antigen
with the protein phosphatase 2A is essential for this activity. Hence,
the ability to drive quiescent Swiss 3T3 cells into S phase results
from the capacity of large T antigen to transactivate DNA synthesis
enzymes by its interaction with retinoblastoma-type proteins and from
the potential of the large and the small T antigens together to
stimulate cyclin A synthesis and cyclin A- and cyclin E-dependent
protein kinase activity.
 |
INTRODUCTION |
DNA tumorviruses preferentially
infect differentiated and, therefore, growth-arrested cells. For their
replication, however, they require cells in S phase because they depend
on replication functions of the host cell. To cope with this situation,
these viruses carry in their genomes the information for a few proteins which interfere with the growth and cell cycle regulation of the host
cells (reviewed in reference 22). The "early
region" of simian virus 40 (SV40), for example, encodes the large and
the small tumor antigens, and that of polyomavirus (Py) encodes the large, the middle, and the small T antigens (LT, MT, and ST,
respectively). At least one of these proteins acts by deregulating
cellular transcription. This is true for the large T antigens of SV40
and Py but also for the E1A protein of adenovirus and for the E7
protein of human papillomavirus. Major targets of these proteins are
the so-called pocket proteins, the retinoblastoma protein pRB and its
relatives, p107 and p130. These proteins control the activity of
members of a family of transcription factors called E2F. By binding to E2Fs, pocket proteins inhibit their transcriptional activity. Growth
factor-induced signal transduction pathways lead to the phosphorylation
of the pocket proteins, which results in their removal from E2F and
consequently in promoter activation (reviewed in reference
6). The viral proteins have the capacity to bind to
the underphosphorylated form of the pocket proteins, causing their
removal from E2F and the activation of transcription. One class of
genes targeted by the viral proteins is that encoding enzymes involved
in DNA replication and in precursor production (reviewed in reference
22).
We have previously produced Swiss 3T3 cells carrying the information of
Py LT and/or Py ST in hormone-inducible form (26). When
dexamethasone at a concentration of 1 µmol/liter is added to cultures
of such cells, T antigen(s) can be readily detected by immunoblotting
about 4 h thereafter. The amount of viral protein remains high for
more than 36 h in the presence of the hormone. We found that the
addition of dexamethasone to 3T3 LT or to 3T3 ST cells causes only a
few percent of serum-starved, quiescent cells to move into S phase
within 32 h after induction of the T antigen. In contrast,
expression of both viral proteins drives about 30% of the cells into S
phase (26). We could show that, despite the failure to
induce S phase in a sizable fraction of cells, expression of Py LT in
quiescent mouse fibroblasts results in efficient transactivation of
S-phase-specific enzymes and that this is dependent on the interaction
of the T antigen with pocket proteins (23, 27).
Cyclins have substantial functions in cell cycle progression (reviewed
in reference 41). Cyclin E is involved in S phase entry, and cyclin A plays an important role in the induction as well as
in the advancement of S phase (5, 11, 28, 31, 36, 37, 44,
49). Protein and mRNA levels of cyclin A are hardly detectable in
G0/G1 and increase at the G1/S
border, while cyclin E levels of cells in G0/G1
vary in different cell lines and cell types (12, 14, 54,
55). We therefore examined whether Py T antigens were able to
induce cyclin E and cyclin A in serum-starved Swiss 3T3 fibroblasts. We
found that while cyclin E levels were significant in quiescent cells
and did not show a strong increase after induction of Py LT and Py ST,
cyclin A was not detectable in arrested cells and both Py LT and Py ST were able to promote cyclin A production. Importantly, however, Py ST
caused a strong rise of cyclin A-dependent protein kinase activity and,
together with LT, of cyclin E-associated kinase activity. These latter
activities correlated with the Py ST-induced phosphorylation and
degradation of the cyclin-dependent kinase inhibitor
p27Kip1. The proficiency of Py ST to interfere with protein
phosphatase 2A (PP2A) appears to be essential for this reaction. We
propose that S-phase induction by Py LT and Py ST in quiescent Swiss
3T3 cells is due to the capacity of Py LT to elicit the synthesis of
DNA replication enzymes and the combined activities of Py LT and Py ST
in the production of S-phase-specific cyclins and cyclin-dependent kinase activities.
 |
MATERIALS AND METHODS |
Cell culture and transfections.
Swiss 3T3 cells and derived
cells conditionally expressing the Py T antigens (26) were
maintained in Dulbecco's modified Eagle's medium supplemented with
10% fetal calf serum (FCS), penicillin (60 µg/ml), and streptomycin
(100 µg/ml) in a 7.5% CO2 atmosphere. For growth arrest,
asynchronously growing cells were seeded at 5 × 105
cells per 100-mm-diameter petri dish; the next day, the serum concentration was reduced to 0.2% for 72 h. Cells were then
either growth induced by addition of fresh medium containing 20% FCS or treated with dexamethasone at a concentration of 10
6
mol/liter. Cell cycle distribution analysis was performed by flow
cytometry (fluorescence-activated cell sorting [FACS]) using a Partec
PAS-II as described previously (26). Transfections were
performed overnight with 5 µg of DNA by the standard Polybrene technique.
Expression plasmids.
The plasmid carrying the Py ST PP2A
binding mutant ins107AL (pBluescript
pyst[ins107AL]) (2) was a kind gift of T. Roberts (Dana Farber Cancer Institute). For inducible expression, the mutant was cloned into the expression vector pMShygro (a pMSG plasmid
[Pharmacia] where the hygromycin resistance gene was inserted in
place of the gpt gene).
Antibodies, protein extraction, and immunoblotting.
An
affinity-purified rabbit polyclonal antibody raised against a cyclin
A-glutathione S-transferase fusion protein produced in
Escherichia coli was used to detect cyclin A. Cyclin E was detected by using a specific antibody (M-20) purchased from Santa Cruz.
The same antibodies were used for the immunoprecipitation and histone
H1 kinase experiments. p27Kip1 was immunoprecipitated with
an antibody from Santa Cruz (M-197) and detected on immunoblots with a
monoclonal antibody (catalog no. K25020) from Transduction
Laboratories. Anti-p21Cip1 antibody (M-19) was purchased
from Santa Cruz.
Cells were harvested and lysed in buffer A (20 mM Tris-Cl [pH 8.0],
100 mM NaCl, 1 mM EDTA, 0.5% NP-40, 2 mM phenylmethylsulfonyl fluoride, 20 µg of aprotinin per ml, 0.5 mM NaF, 0.5 mM
Na3VO4) as described elsewhere (1).
The whole-cell lysates were either directly subjected to gel
electrophoresis followed by immunoblotting to a nitrocellulose membrane
or used for immunoprecipitations. For the immunoblot experiments, the
lysates were mixed with protein sample buffer (100 mM Tris-Cl [pH
6.8], 20% glycerol, 0.01% bromophenol blue, 10%
-mercaptoethanol, 5% sodium dodecyl sulfate [SDS]) and heated for
5 min at 95°C. Sixty micrograms of protein was loaded on
an SDS-polyacrylamide gel per lane. The respective proteins were
detected by a chemiluminescence reaction (Renaissance; NEN).
Immunoprecipitation, histone 1 kinase assay, and phosphatase
treatment.
For the kinase assay, 200 µg of protein from
whole-cell lysates was subjected to immunoprecipitation at 4°C
overnight. The immunocomplexes were washed three times with buffer A
and one time with kinase buffer (50 mM HEPES [pH 7.5], 10 mM
MgCl2, 1 mM dithiothreitol, 25 µM ATP). The kinase
reaction containing 5 µg of histone H1 and 10 µCi of
[
-32P]ATP in a final volume of 25 µl of kinase
buffer was incubated for 30 min at 30°C. The supernatant was mixed
with protein sample buffer, heated at 95°C for 5 min, and applied to
a 12.5% polyacrylamide-SDS gel. The gel was stained with Coomassie
brilliant blue dye to check for equal loading with histone and dried.
Labelled histone H1 was detected by autoradiography. The relative
amounts were calculated with the help of a phosphorimager (Storm 840;
Molecular Dynamics) as well as by liquid scintillation counting.
For p27
Kip1 immunoprecipitation, 80 µg of protein from
whole-cell lysates was incubated at 4°C for 60 min with antibody and
then
for an additional 60 min with protein A-Sepharose. The
immunocomplexes
were washed twice with complete buffer A and once
with buffer
A without NaF and Na
3VO
4. In the
case of phosphatase treatment,
the complexes were once more
washed with

phosphatase buffer
(New England BioLabs). The
phosphatase reaction was performed
as suggested by the distributor with
300 U of enzyme. The immunoprecipitates
were suspended in sample
buffer, heated at 95°C for 5 min, and
analyzed by SDS-polyacrylamide
gel electrophoresis (PAGE) and
Western
blotting.
 |
RESULTS |
Induction of cyclin A and cyclin E by Py T antigens.
Considering that besides the enzymes involved in DNA synthesis, the
S-phase-specific cyclins E and A are necessary for cells to pass the
G1/S border, we examined the levels of these cyclins in
quiescent 3T3 LT, 3T3 ST, and 3T3 LTST cells producing the indicated
viral proteins under a hormone-inducible promoter after addition of
dexamethasone. These levels were compared with the quantities of the
cyclins induced by addition of serum (Fig.
1). Almost undetectable amounts of cyclin
A were present in serum-arrested, quiescent fibroblasts. Addition
of serum resulted in a strong increase after 16 and 24 h.
Cytofluorometric analysis revealed that these cells began to enter S
phase after 16 h and the percentage of cells in S phase reached
its maximum after about 24 h (Fig. 1C). While the amounts of
cyclin A induced by Py LT were relatively low, when compared to serum,
Py ST displayed a strong capacity to induce the protein. Together, Py
LT and Py ST were as efficient in cyclin A induction as serum (Fig.
1A). A quantitation of the blot is included (Fig. 1A, see the graph
below the immunoblot); this shows that Py LT alone induces only about
25% of the amount of cyclin A induced by both T antigens together.
Most remarkably, an intact binding site for pRB and the other pocket
proteins within the large T antigen was dispensable for this function.
A mutated viral protein in which the glutamic acid residue within the
LXCXE motif of the RB binding site was mutated to aspartic acid and which was previously found to be inactive in transactivating DNA synthesis enzymes (23, 27) was almost as active in producing cyclin A as was the wild-type protein. This result suggests that the
pocket proteins play no role in the stimulation of cyclin A gene
expression by Py LT in Swiss 3T3 cells.

View larger version (41K):
[in this window]
[in a new window]
|
FIG. 1.
Cyclin A but not cyclin E is strongly induced by Py LT
and ST. Western blot analysis of protein extracts from conditionally T
antigen-expressing Swiss 3T3 cells is shown. The cells were serum
deprived and treated subsequently with dexamethasone (Dexa) for the
indicated times. For comparison, arrested cells were reinduced with
serum. Cyclin A (A) and cyclin E (B) were detected by using rabbit
polyclonal antibodies. For the quantitation shown below the Western
blots, the expression level of the respective cyclin in arrested cells
was arbitrarily set at 1. (C) Samples for flow cytometric analysis
(FACS) were prepared in parallel to the protein extracts. The
percentage of cells in the respective phases of the cell cycle either
after 72 h of serum starvation (arr) or after 32 h of
dexamethasone induction is shown for all cell lines. Cell cycle phase
distribution after serum stimulation is shown for 3T3 cells only since
the T antigen-expressing cell lines showed a similar profile. Data
represent mean values of at least three independent experiments.
Standard deviation did in no case exceed 10%.
|
|
Cyclin E, in contrast, was present in quiescent cells at significant
levels and was further induced to a small extent by addition
of serum
or by the expression of the viral proteins (Fig.
1B).
However, addition
of dexamethasone in a concentration used for
the induction of the
synthesis of the T antigens also resulted
in some increase of cyclin E
levels in 3T3 cells not expressing
these proteins. It is, therefore,
not entirely clear to which
extent the T antigens contribute to
the rise in the amounts of
cyclin
E.
Strong cyclin-dependent kinase activity depends on ST.
The
efficient production of cyclin A by Py T antigens in quiescent
fibroblasts coincides with the previously found capacity of the two T
antigens together to efficiently induce S phase in serum-starved Swiss
3T3 cells (26). Since it is well established that the cyclin
E- and cyclin A-dependent kinase (cdk2) activities are required for
S-phase induction, we determined these activities in extracts from
serum-starved cells producing T antigens and compared them with those
measured after growth stimulation by addition of serum (Fig.
2). As expected, these activities were low in quiescent cells. Production of Py LT gave rise to low levels of
cyclin E/cdk2 and cyclin A/cdk2 activities in serum-starved cells. It
is intriguing that the induction of cyclin A- and cyclin E-dependent
kinase by Py LT required an intact pocket protein binding site within
the viral protein (Fig. 2), which contrasts with the observation that
this site was dispensable for cyclin A induction (Fig. 1). This
requirement is therefore independent of the production of the cyclin.

View larger version (68K):
[in this window]
[in a new window]
|
FIG. 2.
LT and ST together strongly induce cyclin A/Cdk2 and
cyclin E/Cdk2 activity. Cyclin A-associated (A) and cyclin E-associated
(B) histone H1 kinase activities at the indicated time points were
measured after immunoprecipitation of the cyclins from the lysates
described in Fig. 1. Quantitation was done by using
phosphorimager software and by liquid scintillation counting. Mean
values of three independent experiments are shown. Grey bars represent
the most intensive signal after serum induction; white bars represent
the most intensive after dexamethasone (Dexa) induction. The data are
expressed as percent values of the maximum (i.e., 24 h plus 20%
FCS for cyclin A-associated kinase and 16 h plus 20% FCS for
cyclin E-associated kinase).
|
|
Py ST alone caused strong cyclin A-dependent and, to a weaker extent,
cyclin E-dependent kinase activity, but both T antigens
together were
as efficient as addition of serum in stimulating
cyclin A/cdk2.
Interestingly, cyclin E/cdk2 activity was also
strongly generated in
LTST-expressing
cells.
Activation of cyclin-dependent kinase is paralleled by small
T-dependent inactivation of p27Kip1.
Cyclin-dependent
kinases are regulated by binding to the cyclin, by phosphorylation, and
by the activity of kinase inhibitors (reviewed in references
7 and 42). Two such inhibitors,
p27Kip1 and p21Cip1/WAF1, regulate cdk2. Since
the slightly elevated protein levels of cyclin E could not account for
the observed strong induction of cyclin E/cdk2 activity in 3T3 LTST
cells, we tested the effect of Py LT, Py ST, and Py LTST on the amounts
of p27 and p21 (Fig. 3 and
4). As expected, the level of p27 was
high in quiescent cells and addition of serum rapidly caused its
removal (Fig. 3A), most likely by proteasome-dependent degradation
(32, 51). Py LT did not change the levels of p27 within
32 h. In contrast, Py ST first caused a shift of the p27-specific
band towards slower migration during denaturing PAGE, which was then
followed by a gradual decrease of the amount of p27 in cell extracts.
The same effect was observed in cells producing Py LT and Py ST
together. The shift of p27 was due to phosphorylation of the protein
because treatment of p27 immunoprecipitates with a protein phosphatase caused the return to the faster-migrating form (Fig. 3B). Degradation of the phosphorylated form of p27 by the proteasome system was finally
confirmed by the observation that an inhibitor of the proteasome
degradation pathway, MG-132, gave rise to a stabilization of the
phosphorylated form of p27 (Fig. 3C). p27 in 3T3 LT cells appears as a
broader band which sometimes (as in this figure) split into a double
band. This may be a property of this cell line, since it is not seen in
3T3 LTST cells.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 3.
ST causes the phosphorylation and subsequent degradation
of the kinase inhibitor p27Kip1. (A) Western blot analysis
of the protein extracts described in Fig. 1 using a monoclonal antibody
specific for p27 is shown. (B) To demonstrate that the mobility shift
observed for p27 in cells expressing ST is due to phosphorylation, p27
was immunoprecipitated from extracts of 3T3 LTST cells, and the
immunocomplexes were subjected to protein phosphatase treatment and
analyzed by Western blotting. (C) LTST-expressing, serum-starved cells
were incubated with dexamethasone for the indicated times. In the case
of MG-132 treatment, the cells were treated with dexamethasone for
16 h. MG-132 was then added to the medium, and the cells were
incubated for an additional 8 h in the presence of dexamethasone
and MG-132. The levels of p27 were analyzed by Western blotting. Dexa,
dexamethasone.
|
|

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 4.
Induction of p21Cip1 by LT depends on an
intact pocket protein binding motif within the viral antigen. Lysates
of cells expressing either LT, ST, or both, which were serum starved
and subsequently incubated with dexamethasone for 24 h, were
subjected to SDS-PAGE and immunoblotting. p21 was detected by using a
polyclonal antibody. For comparison of p21 induction, extracts of
growing and UV-irradiated (18 J/m2; extract was prepared
9 h thereafter) 3T3 cells are shown in the first two lanes. Fold
induction represents the ratio of the dexamethasone-induced amount to
the uninduced amount.
|
|
Analyses of p21 gave a different result. T antigens did not provoke a
decrease in the amount of this protein; rather, Py LT
caused an
induction of p21 (Fig.
4). The mutant LTRB

did not
display this activity which therefore requires an interaction
of Py LT
with pRB or its relatives. This is in agreement with
a recent report
indicating a regulation of the p21 promoter by
E2F (
13). It
is important to note, however, that the increase
in the amount of p21
caused by Py LT was considerably lower than
that achieved by treating
cells with UV light, which is particularly
evident from the
quantitation of the immunoblots included in Fig.
4. The increase
corresponded approximately with that accompanying
a growth stimulation
of cells by serum (data not shown). This
amount of the inhibitor does
not result in an inhibition of cell
proliferation. On the contrary,
earlier results point to p21 as
an important component of catalytically
active kinases and even
to a positive role in promoting the assembly of
active kinase
complexes (
20,
56). Taken together, our
results allow the
conclusion that p27 is the major negative regulator
of cyclin/cdk2
activity which is targeted by Py
ST.
The interaction of Py ST with PP2A is required for p27
degradation and stimulation of cdk2 activity.
The small T
antigens of polyomavirus and SV40 interact with the PP2A
(2). This interaction results in a disturbance of the
tripartite structure of this enzyme whereby the B subunit is replaced
by the viral protein. This causes an inactivation or a change in
the substrate specificity of the enzyme. A first hint that PP2A might
be targeted by Py ST to result in p27 phosphorylation came from
the observation that addition of okadaic acid, an inhibitor of protein
phosphatases, to quiescent cells gave rise to a shift of the
p27-specific band similar to the one induced by Py ST (data not shown).
To investigate a potential role of the PP2A binding capacity of Py ST
in the reduction of p27 levels, we used a mutant of Py ST [ST
(ins107AL)] with modifications in the binding site for PP2A
which almost completely destroyed the capacity of the viral protein to
bind to the phosphatase (2). The mutated cDNA was cloned
into a vector for dexamethasone-dependent production of the protein and
was then stably transfected into Swiss 3T3 and 3T3 LT cells. The
expression of the viral proteins after addition of hormone was measured
by immunoblotting equal amounts of protein from extracts of
logarithmically growing cells. As shown in Fig. 5, the different cell lines express
similar amounts of LT antigen or of ST protein. In particular, mutant T
antigens are certainly not produced in lower amounts than the wild-type
proteins. Induction of mutated Py ST in quiescent cells did not
result in a destruction of p27, and the same was true when wild-type Py
LT and mutated Py ST were induced together in serum-starved 3T3
LTST(ins107AL) cells (Fig.
6A). Accordingly, cyclin-dependent kinase
activities remained low (Fig. 6B). As expected, cytofluorometric
analyses showed that these conditions did not lead to S-phase induction above that seen with Py LT alone (Fig. 6C). These results are consistent with the interpretation that the interaction of Py ST with
PP2A plays an important role in the stimulation of cyclin-dependent cdk2 activity and that this activity is important for S-phase induction.

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 5.
The mutated form of ST containing a defective PP2A
binding site is expressed at levels comparable to those of the
wild-type ST. All T antigen-expressing cells used for this study were
induced with dexamethasone for 16 h. Whole-cell extracts were
prepared and subjected to Western blot analysis. An extract of the
Py-transformed cell line Cop8 was included as a positive control. The T
antigens were detected by using a polyclonal antibody raised against
the N terminus, thus recognizing all three T antigens. Arrows indicate
LT, MT, and ST (from top to bottom).
|
|

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 6.
A mutated form of ST deficient for PP2A interaction is
unable to cause the elimination of p27 from arrested cells. (A)
Western blot analysis for p27 of cells conditionally expressing
ST(ins107AL) or wild-type LT and
ST(ins107AL) together, respectively, is shown. (B) Cyclin A-
and cyclin E-dependent histone H1 kinase activities were determined in
LTST(ins107AL) expressing cells at the indicated time
points. (C) Cell cycle phase distribution profile of 72-h serum-starved
(arr) and 32-h dexamethasone-induced 3T3 LTST(ins107AL)
cells as determined by FACS analysis is shown.
|
|
 |
DISCUSSION |
The cyclins E and A were shown to be important for S-phase
induction and regulation (5, 11, 28, 31, 36, 37, 44, 49; reviewed in reference 41). Several
substrates for cyclin E/cdk2 and cyclin A/cdk2 are known, but some
important targets may yet be undiscovered. For instance, cyclin E/cdk2
was found to phosphorylate p27 on threonine 187 (40) and to
associate with components for the SWI-SNF complex that alters chromatin structure (39) and with NPAT, a novel substrate with
S-phase-promoting function (57). Together with cdk2 (and
later in the cell cycle together with cdk1 [cdc2]), cyclin A
phosphorylates proteins playing important roles in S phase and
thereafter (reviewed in reference 41). For instance,
cyclin A was found to bind to complexes of E2F with p107 (8, 21,
24, 43) and to phosphorylate E2F1 (probably also E2F2 and E2F3)
and DP1, causing inhibition of their transcriptional activity in S
phase (17, 18). It also phosphorylates, and thereby
activates, transcription factor B-myb (38, 58). Cyclin A
stimulates SV40 and cellular DNA replication in vitro (9,
19), and several components of the replication machinery (replication protein RP-A, DNA polymerase
, and the large T antigen) were found to be modified by cyclin-dependent kinases with consequences for their activity (52, 53). Importantly, cyclin A/cdk2
phosphorylates cdc6 protein, thereby stimulating its release from
chromatin and its export from the nucleus (30). cdc6p is
essential for setting up the prereplicative complex and is central to
the once-per-cell cycle regulation of DNA replication (reviewed in
reference 25). Viral proteins can bind cyclin A
directly (references 1, 4, and 50
and our unpublished observations). It is so far unknown whether this
binding has consequences for the function of cyclin A during S phase.
Considering the importance of cyclins E and A in S-phase induction, it
is not surprising that several viral proteins were found to stimulate
their synthesis (1, 29, 50, 54, 55). In the case of Py,
efficient transactivation of cyclin A is not achieved by LT alone but
is provided by the combined activities of Py LT and Py ST. Our
finding that the T antigens in addition permit strong induction
of cyclin E/cdk2 and cyclin A/cdk2 activity thus can explain the
proficient initiation of S phase if the two viral proteins are produced
in serum-starved cells (26). It is of interest that
although binding of pRB or the other pocket proteins by Py LT is not
required for cyclin A transactivation, this activity seems to be
essential for the capacity of Py LT to induce cyclin A/cdk2 activity.
The role of pRB in the transcriptional regulation of cyclin A gene
expression is still controversial. Our observation argues against an
involvement of pRB in the transactivation of cyclin A by Py LT, which
is in agreement with the report that a mutant of SV40 LT antigen (K1),
which is unable to bind pocket proteins, can induce cyclin A
(29). Furthermore, Henglein et al. (12) reported
that regulation of cyclin A promoter-luciferase constructs is normal in
tumor-derived cell lines lacking pRB. On the other hand, cyclin A
regulation was found to be aberrant in normal diploid mouse cells in
which the RB gene was eliminated; no effect was observed in cells from
p107 and p130 knockout mice (33). Nevertheless, the
transactivation of cyclin A by adenovirus E1A protein was
reported to require an interaction of the viral protein with the pocket
protein p107 (55). Since both SV40 LT and Py LT mutated
in the LXCXE domain are defective in p107 as well as pRB binding,
this indicates that the mechanism of transactivation of cyclin A
by the viral proteins may differ. It remains to be clarified whether Py
LT has a direct effect on the cyclin A promoter and which sequences
within the viral protein are involved.
Besides Py LT, Py ST also has the potential to transactivate cyclin A. This is in accord with a report on a similar activity of SV40 small T
protein (34). While for the latter protein an involvement of
the chaperone binding site, the so-called J domain recently discovered
in T antigens (for examples, see references 3, 16,
and 47), was suggested to be necessary for this activity (34), the mechanism by which Py ST transactivates
cyclin A has to be investigated. Furthermore, an important role of Py ST in stimulating cyclin E- and cyclin A-dependent cdk2 activity is
obvious from the results presented. They also suggest a mechanism by
which Py ST accomplishes this stimulation. This viral protein is able
to cause a rapid decrease in the amount of the cdk inhibitor p27, an
activity for which the binding of Py ST to the PP2A is essential. Our
data also show that through the action of Py ST, p27 is converted into
a (hyper)phosphorylated form. This agrees with the mechanism suggested
for cell cycle-dependent inactivation of p27 involving a
phosphorylation step which sensitizes the protein for degradation by
the proteasome system (32, 51). It was shown previously that
SV40 ST antigen, through its interaction with PP2A, stimulates the
mitogen-activated protein (MAP) kinase pathway of signal transduction
(10, 45, 46) and that p27 can be phosphorylated by MAP
kinase in vitro (15). Finally, there is evidence that
phosphorylation of p27 precedes the degradation of the protein
(32, 51). All these data support the above model for the
function of Py ST. Although our data do not provide direct proof, it is
an attractive hypothesis that activation of the MAP kinase pathway by
Py ST may lead to the elimination of a crucial negative regulator of
cell proliferation in vivo. It is interesting that the shift to slower
migration of p27 is not so obvious in the case of serum stimulation of
arrested cells (Fig. 3). This might indicate that the phosphorylation
step is the rate-limiting one in the case of serum stimulation while
components of the degradation machinery involved in the destruction of
p27 may be readily available under these conditions. In contrast, in
the case of serum-deprived cells expressing Py T antigens, these
components might be limiting, thereby allowing the slower-migrating phosphorylated form of p27 to become clearly visible before the protein
is degraded.
In contrast to the Py ST-induced elimination of p27, Py LT provokes an
increase in the level of p21. This is dependent on the ability of the
protein to interact with pRB and therefore likely results from a
transactivation of the E2F-regulated promoter of the p21 gene
(13). The cellular level of p21 attained by expression of Py
LT in serum-starved Swiss 3T3 fibroblasts is close to that obtained by
serum stimulation and considerably lower than that induced by UV
treatment of cells. While the latter condition causes cell cycle arrest
due to inhibition of cyclin-dependent kinases, the lower amounts
induced by serum or by Py LT appear to support the generation of active
cyclin/cdk complexes (20, 56). The induction of p21 by Py LT
may thus be an essential part of the reaction leading to high cyclin
kinase activity. Several of our observations provide evidence for this:
first, Py LT gives rise to some cyclin A and cyclin E/cdk2 activity
even in the absence of Py ST and, hence, in the presence of p27.
Second, expression of Py ST alone is not sufficient to induce high
cyclin E-dependent kinase activity, despite the removal of p27.
Finally, the mutant of Py LT defective in pRB binding, although
functional in the induction of cyclin A protein, is not able to induce
cyclin E or cyclin A/cdk2 activity. Taken together, these results
indicate that it may require both the induction of p21 by Py LT and the elimination of p27 by Py ST to adequately activate cyclin E- and cyclin
A-dependent protein kinase.
Shortly before the preparation of this manuscript was finished, a paper
was published (35) in which the cooperation of SV40 large
and small T antigens in the induction of cell cycle rerentry of
serum-starved human diploid fibroblasts was described. As in our study
on Py T antigens, both proteins are required and major activities were
found to be the transactivation of cyclin A and the activation of
cyclin A/cdk2 to which small T contributes by eliminating p27. However,
there are also significant differences. For instance, while we find
that Py LT induces p21, SV40 LT was found to inhibit p21 expression.
This difference may lie in the well-known ability of SV40 LT to
interact with and functionally inactivate p53, an activity not found
for Py LT. In fact, our earlier observation that Py LT does not
interfere with the UV-induced and p53-dependent induction of high
levels of p21 in REF52 cells (48) supports this assumption.
In conclusion, our observations support the view that the
production of S-phase-specific enzymes (which results from the
function of Py LT) and a sufficient generation of cyclin E- and
cyclin A-dependent protein kinase activities (which are
achieved by the combined actions of Py LT and Py ST) are required
to adequately drive quiescent Swiss 3T3 cells into S phase.
 |
ACKNOWLEDGMENTS |
We thank Peter Stiegler for help in the initial experiments, in
particular for the production of a polyclonal antibody against murine
cyclin A, and Egon Ogris and Peter Stiegler for helpful discussions.
This work was supported by grants from the Fonds zur Förderung
der wissenschaftlichen Forschung and the Herzfelder'sche Familienstiftung.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Institut
für Molekularbiologie, Universität Wien, Dr. Bohrgasse
9, A-1030 Vienna, Austria. Phone: 43-1-4277-61704. Fax:
43-1-4277-61705. E-mail: Wi{at}Mol.Univie.Ac.At.
 |
REFERENCES |
| 1.
|
Adamczewski, J. P.,
J. V. Gannon, and T. Hunt.
1993.
Simian virus 40 large T antigen associates with cyclin A and p33cdk2.
J. Virol.
67:6551-6557[Abstract/Free Full Text].
|
| 2.
|
Campbell, K. S.,
K. R. Auger,
B. A. Hemmings,
T. M. Roberts, and D. C. Pallas.
1995.
Identification of regions in polyomavirus middle T and small T antigens important for association with protein phosphatase 2A.
J. Virol.
69:3721-3728[Abstract].
|
| 3.
|
Campbell, K. S.,
K. P. Mullane,
I. A. Aksoy,
H. Stubdal,
J. Zalvide,
J. M. Pipas,
P. A. Silver,
T. M. Roberts,
B. Schaffhausen, and J. A. DeCaprio.
1997.
DNAJ/hsp40 chaperone domain of SV40 large T antigen promotes efficient viral DNA replication.
Genes Dev.
11:1098-1110[Abstract/Free Full Text].
|
| 4.
|
Cannella, D.,
J. M. Roberts, and R. Fotedar.
1997.
Association of cyclin A and cdk2 with SV40 DNA in replication initiation complexes is cell cycle dependent.
Chromosoma
105:349-359[Medline].
|
| 5.
|
Duronio, R. J.,
A. Brook,
N. Dyson, and P. H. Farrell.
1996.
E2F-induced S phase requires cyclin E.
Genes Dev.
10:2505-2513[Abstract/Free Full Text].
|
| 6.
|
Dyson, N.
1998.
The regulation of E2F by pRB-family proteins.
Genes Dev.
12:2245-2262[Free Full Text].
|
| 7.
|
Elledge, S. J.,
J. Winston, and J. W. Harper.
1996.
A question of balance: the role of cyclin-kinase inhibitors in development and tumorigenesis.
Trends Cell Biol.
6:388-392.
[Medline] |
| 8.
|
Ewen, M. E.,
B. Faha,
E. Harlow, and D. M. Livingston.
1992.
Interaction of p107 with cyclin A independent of complex formation with viral oncoproteins.
Science
255:85-87[Abstract/Free Full Text].
|
| 9.
|
Fotedar, A.,
D. Cannella,
P. Fitzgerald,
T. Rousselle,
S. Gupta,
M. Doree, and R. Fotedar.
1996.
Role for cyclin A-dependent kinase in DNA replication in human S phase cell extracts.
J. Biol. Chem.
271:31627-31637[Abstract/Free Full Text].
|
| 10.
|
Frost, J. A.,
A. S. Alberts,
E. Sontag,
K. Guan,
M. C. Mumby, and J. R. Feramisco.
1994.
Simian virus 40 small t antigen cooperates with mitogen-activated kinases to stimulate AP-1 activity.
Mol. Cell. Biol.
14:6244-6252[Abstract/Free Full Text].
|
| 11.
|
Girard, E.,
U. Strausfeld,
A. Dernandez, and N. J. C. Lamb.
1991.
Cyclin A is required for the onset of DNA replication in mammalian cells.
Cell
67:1169-1179[Medline].
|
| 12.
|
Henglein, B.,
X. Chenivesse,
J. Wang,
D. Eick, and C. Brechot.
1994.
Structure and cell cycle-regulated transcription of the human cyclin A gene.
Proc. Natl. Acad. Sci. USA
91:5490-5494[Abstract/Free Full Text].
|
| 13.
|
Hiyama, H.,
A. Iavarone, and S. A. Reeves.
1998.
Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F.
Oncogene
16:1513-1523[Medline].
|
| 14.
|
Huet, X.,
J. Rech,
A. Plet,
A. Vie, and J. M. Blanchard.
1996.
Cyclin A expression is under negative transcriptional control during the cell cycle.
Mol. Cell. Biol.
16:3789-3798[Abstract].
|
| 15.
|
Kawada, M.,
S. Yamagoe,
Y. Murakami,
K. Suzuki,
S. Mizuno, and Y. Uehara.
1997.
Induction of p27Kip1 degradation and anchorage independence by Ras through the MAP kinase signaling pathway.
Oncogene
15:629-637[Medline].
|
| 16.
|
Kelly, W., and C. Georgopoulos.
1997.
The T/t common exon of simian virus 40, JC and BK polyomavirus T antigens can functionally replace the J-domain of the Escherichia coli DnaJ molecular chaperone.
Proc. Natl. Acd. Sci. USA
94:3679-3684[Abstract/Free Full Text].
|
| 17.
|
Kitigawa, M.,
H. Higashi,
I. Suzuki-Takahashi,
K. Segawa,
S. K. Hanks,
Y. Taya,
S. Nishimura, and A. Okuyama.
1995.
Phosphorylation of E2F-1 by cyclin A-cdk2.
Oncogene
10:229-236[Medline].
|
| 18.
|
Krek, W.,
M. E. Ewen,
S. Shirodkar,
Z. Arany,
W. G. Kaelin Jr, and D. M. Livingston.
1994.
Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase.
Cell
78:161-172[Medline].
|
| 19.
|
Krude, T.,
M. Jackman,
J. Pines, and R. A. Laskey.
1997.
Cyclin/cdk-dependent initiation of DNA replication in a human cell-free system.
Cell
88:109-119[Medline].
|
| 20.
|
LaBaer, J.,
M. D. Garrett,
L. F. Stevenson,
J. M. Slingerland,
C. Sandhu,
H. S. Chou,
A. Fattaey, and E. Harlow.
1997.
New functional activities for the p21 family of CDK inhibitors.
Genes Dev.
11:847-862[Abstract/Free Full Text].
|
| 21.
|
Lees, E.,
B. Faha,
V. Dulic,
S. I. Reed, and E. Harlow.
1992.
Cyclin E/cdk2 and cyclin A/cdks kinases associate with p107 and E2F in a temporally distinct manner.
Genes Dev.
6:1874-1885[Abstract/Free Full Text].
|
| 22.
|
Moran, E.
1993.
DNA tumorvirus transforming proteins and the cell cycle.
Curr. Opin. Genet. Dev.
3:63-70[Medline].
|
| 23.
|
Mudrak, I.,
E. Ogris,
H. Rotheneder, and E. Wintersberger.
1994.
Coordinated trans activation of DNA synthesis- and precursor-producing enzymes by polyomavirus large T antigen through interaction with the retinoblastoma protein.
Mol. Cell. Biol.
14:1886-1892[Abstract/Free Full Text].
|
| 24.
|
Mudryi, M.,
S. H. Devoto,
S. W. Hiebert,
T. Hunter,
J. Pines, and J. R. Nevins.
1991.
Cell cycle regulation of the E2F transcription factor involves interaction with cyclin A.
Cell
65:1243-1253[Medline].
|
| 25.
|
Newlon, C. S.
1997.
Putting it all together: building a prereplicative complex.
Cell
91:717-720[Medline].
|
| 26.
|
Ogris, E.,
I. Mudrak, and E. Wintersberger.
1992.
Polyomavirus large and small T antigens cooperate in induction of the S phase in serum-starved 3T3 mouse fibroblasts.
J. Virol.
66:53-61[Abstract/Free Full Text].
|
| 27.
|
Ogris, E.,
H. Rotheneder,
I. Mudrak,
A. Pichler, and E. Wintersberger.
1993.
A binding site for transcription factor E2F is a target for trans activation of murine thymidine kinase by polyomavirus large T antigen and plays an important role in growth regulation of the gene.
J. Virol.
67:1765-1771[Abstract/Free Full Text].
|
| 28.
|
Ohtsubo, M.,
A. M. Theodoras,
J. Schumacher,
J. M. Roberts, and M. Pagano.
1995.
Human cyclin E, a nuclear protein essential for the G1-to-S phase transition.
Mol. Cell. Biol.
15:2612-2624[Abstract].
|
| 29.
|
Oshima, J.,
K. E. Steinmann,
J. Campbell, and R. Schlegel.
1993.
Modulation of cell growth, p34cdc2 and cyclin A levels by SV40 large T antigen.
Oncogene
8:2987-2993[Medline].
|
| 30.
|
Otzen Petersen, B.,
J. Lukas,
C. Storgard Sorensen,
J. Bartek, and K. Helin.
1999.
Phosphorylation of mammalian CDC6 by cyclin A/cdk2 regulates its subcellular localization.
EMBO J.
18:396-410[Medline].
|
| 31.
|
Pagano, M.,
R. Pepperkok,
F. Verde,
W. Ansorge, and G. Draetta.
1992.
Cyclin A is required at two points in the human cell cycle.
EMBO J.
11:961-971[Medline].
|
| 32.
|
Pagano, M.,
S. W. Tam,
A. M. Theodoras,
P. Beer-Romero,
G. DelSal,
V. Chau,
P. R. Yew,
G. F. Draetta, and M. Rolfe.
1995.
A role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.
Science
269:682-685[Abstract/Free Full Text].
|
| 33.
|
Philips, A.,
X. Huet,
A. Plet,
L. Le Cam,
A. Vie, and M. Blanchard.
1998.
The retinoblastoma protein is essential for cyclin A repression in quiescent cells.
Oncogene
16:1373-1381[Medline].
|
| 34.
|
Porras, A.,
J. Bennett,
A. Howe,
K. Tokos,
N. Bouck,
B. Henglein,
S. Sathyamangalam,
B. Thimmapaya, and K. Rundell.
1996.
A novel simian virus 40 early-region domain mediates transactivation of the cyclin A promoter by small-t antigen and is required for transformation in small-t antigen-dependent assays.
J. Virol.
70:6902-6908[Abstract/Free Full Text].
|
| 35.
|
Porras, A.,
S. Gaillard, and K. Rundell.
1999.
The simian virus 40 small-t and large-T antigens jointly regulate cell cycle reentry in human fibroblasts.
J. Virol.
73:3102-3107[Abstract/Free Full Text].
|
| 36.
|
Resnitzky, D.,
L. Hengst, and S. I. Reed.
1995.
Cyclin A-associated kinase activity is rate limiting for entrance into S phase and is negatively regulated in G1 by p27Kip1.
Mol. Cell. Biol.
15:4347-4352[Abstract].
|
| 37.
|
Rosenberg, A. R.,
F. Zindy,
F. Le Deist,
H. Mouly,
P. Metezeay,
C. Brechot, and E. Lamas.
1995.
Overexpression of human cyclin A advances entry into S phase.
Oncogene
10:1501-1509[Medline].
|
| 38.
|
Sala, A.,
M. Kundu,
I. Casella,
A. Engelhard,
B. Calabretta,
L. Grasso,
M. G. Paggi,
A. Giordano,
R. J. Watson,
K. Khalili, and C. Peschle.
1997.
Activation of human B-myb by cyclins.
Proc. Natl. Acad. Sci. USA
94:532-536[Abstract/Free Full Text].
|
| 39.
|
Shanahan, F.,
W. Seghezzi,
D. Parry,
D. Mahony, and E. Lees.
1999.
Cyclin E associates with BAF 155 and BRG1, components of the mammalian SWI-SNF complex, and alters the ability of BRG1 to induce growth arrest.
Mol. Cell. Biol.
19:1460-1469[Abstract/Free Full Text].
|
| 40.
|
Sheaff, R. J.,
M. Groudin,
M. Gordon,
J. M. Roberts, and B. E. Clurman.
1997.
Cyclin E-CDK2 is a regulator of p27Kip1.
Genes Dev.
11:1464-1478[Abstract/Free Full Text].
|
| 41.
|
Sherr, C. J.
1996.
Cancer cell cycles.
Science
274:1672-1677[Abstract/Free Full Text].
|
| 42.
|
Sherr, C. J., and J. M. Roberts.
1995.
Inhibitors of mammalian G1 cyclin-dependent kinases.
Genes Dev.
9:1149-1163[Free Full Text].
|
| 43.
|
Shirodkar, S.,
M. Ewen,
J. A. DeCaprio,
J. Morgan,
D. M. Livingston, and T. Chittenden.
1992.
The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner.
Cell
68:157-166[Medline].
|
| 44.
|
Sobczak-Thepot, J.,
F. Harper,
Y. Florentin,
F. Zindy,
C. Brechot, and E. Puvion.
1993.
Localization of cyclin A at the sites of cellular DNA replication.
Exp. Cell Res.
206:43-48[Medline].
|
| 45.
|
Sontag, E.,
J.-M. Sontag, and A. Garcia.
1997.
Protein phosphatase 2A is a critical regulator of protein kinase C signaling targeted by SV40 small t to promote cell growth and NF- B activation.
EMBO J.
16:5662-5671[Medline].
|
| 46.
|
Sontag, E.,
S. Fedorov,
C. Kambayashi,
D. Robbins,
M. Cobb, and M. C. Mumby.
1993.
The interaction of SV40 small tumor antigen with protein phosphatase 2A stimulates the Map kinase pathway and induces cell proliferation.
Cell
75:887-897[Medline].
|
| 47.
|
Srinivasan, A.,
A. J. McClellan,
J. Vartikar,
I. Marks,
P. Cantalupo,
Y. Li,
P. Whyte,
K. Rundell,
J. L. Brodsky, and J. M. Pipas.
1997.
The amino-terminal transforming region of simian virus 40 large T and small t antigens functions as a J domain.
Mol. Cell. Biol.
17:4761-4773[Abstract].
|
| 48.
|
Stiegler, P.,
S. Schüchner,
V. Lestou, and E. Wintersberger.
1997.
Polyomavirus large T antigen-dependent DNA amplification.
Oncogene
14:987-995[Medline].
|
| 49.
|
Strausfeld, A. P.,
M. Howell,
P. Descombes,
S. Chevalier,
R. E. Rempel,
J. Adamczewski,
J. L. Maller,
T. Hunt, and J. J. Blow.
1996.
Both cyclin A and cyclin E have S-phase promoting (SPF) activity in Xenopus egg extracts.
J. Cell Sci.
109:1555-1563[Abstract].
|
| 50.
|
Tommasino, M.,
J. P. Adamczewski,
F. Carlotti,
C. F. Bath,
R. Manetti,
M. Contori,
F. Cavalieri,
T. Hunt, and L. Crawford.
1993.
HPV 16 E7 protein associates with the protein kinase p33cdk2 and cyclin A.
Oncogene
8:195-202[Medline].
|
| 51.
|
Vlach, J.,
S. Hennecke, and B. Amati.
1997.
Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1.
EMBO J.
16:5334-5344[Medline].
|
| 52.
|
Voitenleitner, C.,
E. Fanning, and H.-P. Nasheuer.
1997.
Phosphorylation of DNA polymerase -primase by cyclin A-dependent kinases regulates initiation of DNA replication in vitro.
Oncogene
14:1611-1615[Medline].
|
| 53.
|
Wang, E. H.,
S. Bhattacharyya, and C. Prives.
1993.
The replication functions of polyomavirus large T antigen are regulated by phosphorylation.
J. Virol.
67:6788-6796[Abstract/Free Full Text].
|
| 54.
|
Zerfass, K.,
A. Schulze,
D. Spitkovsky,
V. Friedman,
B. Henglein, and P. Jansen-Dürr.
1995.
Sequential activation of cyclin E and cyclin A gene expression by human papillomavirus type 16 E7 through sequences necessary for transformation.
J. Virol.
69:6389-6399[Abstract].
|
| 55.
|
Zerfass, K.,
D. Spitkovsky,
A. Schulze,
S. Joswig,
B. Henglein, and P. Jansen-Dürr.
1996.
Adenovirus E1A activates cyclin A gene transcription in the absence of growth factors through interaction with p107.
J. Virol.
70:2637-2642[Abstract].
|
| 56.
|
Zhang, H.,
J. Hannon, and D. Beach.
1994.
P21-containing cyclin kinases exist in both active and inactive states.
Genes Dev.
8:1750-1758[Abstract/Free Full Text].
|
| 57.
|
Zhao, J.,
B. Dynlacht,
T. Imai,
T.-A. Hori, and E. Harlow.
1998.
Expression of NPAT, a novel substrate of cyclin E-CDK2, promotes S-phase entry.
Genes Dev.
12:456-461[Abstract/Free Full Text].
|
| 58.
|
Ziebold, U.,
O. Bartsch,
R. Marais,
S. Ferrari, and K.-H. Klempnauer.
1997.
Phosphorylation and activation of B-myb by cyclin A-cdk2.
Curr. Biol.
7:253-260[Medline].
|
Journal of Virology, November 1999, p. 9266-9273, Vol. 73, No. 11
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Dahl, J., Chen, H. I., George, M., Benjamin, T. L.
(2007). Polyomavirus Small T Antigen Controls Viral Chromatin Modifications through Effects on Kinetics of Virus Growth and Cell Cycle Progression. J. Virol.
81: 10064-10071
[Abstract]
[Full Text]
-
Luo, M., Jones, S. M., Flamand, N., Aronoff, D. M., Peters-Golden, M., Brock, T. G.
(2005). Phosphorylation by Protein Kinase A Inhibits Nuclear Import of 5-Lipoxygenase. J. Biol. Chem.
280: 40609-40616
[Abstract]
[Full Text]
-
Moreno, C. S., Ramachandran, S., Ashby, D. G., Laycock, N., Plattner, C. A., Chen, W., Hahn, W. C., Pallas, D. C.
(2004). Signaling and Transcriptional Changes Critical for Transformation of Human Cells by Simian Virus 40 Small Tumor Antigen or Protein Phosphatase 2A B56{gamma} Knockdown. Cancer Res.
64: 6978-6988
[Abstract]
[Full Text]
-
Dey, D., Dahl, J., Cho, S., Benjamin, T. L.
(2002). Induction and Bypass of p53 during Productive Infection by Polyomavirus. J. Virol.
76: 9526-9532
[Abstract]
[Full Text]
-
Gjoerup, O., Zaveri, D., Roberts, T. M.
(2001). Induction of p53-Independent Apoptosis by Simian Virus 40 Small t Antigen. J. Virol.
75: 9142-9155
[Abstract]
[Full Text]
-
Schuchner, S., Nemethova, M., Belisova, A., Klucky, B., Holnthoner, W., Wintersberger, E.
(2001). Transactivation of Murine Cyclin A by Polyomavirus Large and Small T Antigens. J. Virol.
75: 6498-6507
[Abstract]
[Full Text]
-
Gottlieb, K. A., Villarreal, L. P.
(2001). Natural Biology of Polyomavirus Middle T Antigen. Microbiol. Mol. Biol. Rev.
65: 288-318
[Abstract]
[Full Text]
-
Berjanskii, M. V., Riley, M. I., Xie, A., Semenchenko, V., Folk, W. R., Van Doren, S. R.
(2000). NMR Structure of the N-terminal J Domain of Murine Polyomavirus T Antigens. IMPLICATIONS FOR DnaJ-LIKE DOMAINS AND FOR MUTATIONS OF T ANTIGENS. J. Biol. Chem.
275: 36094-36103
[Abstract]
[Full Text]